Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Oliver T. Stirrup"'
Publikováno v:
BMC Medical Research Methodology, Vol 23, Iss 1, Pp 1-6 (2023)
Abstract Active-control trials, where an experimental treatment is compared with an established treatment, are performed when the inclusion of a placebo control group is deemed to be unethical. For time-to-event outcomes, the primary estimand is usua
Externí odkaz:
https://doaj.org/article/64cf68fd6e1745799dce47f7cc3254de
Autor:
Oliver T. Stirrup, Caroline A. Sabin, Andrew N. Phillips, Ian Williams, Duncan Churchill, Anna Tostevin, Teresa Hill, David T. Dunn, David Asboe, Anton Pozniak, Patricia Cane, David Chadwick, Duncan Clark, Simon Collins, Valerie Delpech, Samuel Douthwaite, David Dunn, Esther Fearnhill, Kholoud Porter, Oliver Stirrup, Christophe Fraser, Anna Maria Geretti, Rory Gunson, Antony Hale, Stéphane Hué, Linda Lazarus, Andrew Leigh-Brown, Tamyo Mbisa, Nicola Mackie, Chloe Orkin, Eleni Nastouli, Deenan Pillay, Andrew Phillips, Caroline Sabin, Erasmus Smit, Kate Templeton, Peter Tilston, Erik Volz, Hongyi Zhang, Keith Fairbrother, Justine Dawkins, Siobhan O’Shea, Jane Mullen, Alison Cox, Richard Tandy, Tracy Fawcett, Mark Hopkins, Clare Booth, Lynne Renwick, Matthias L. Schmid, Brendan Payne, Jonathan Hubb, Simon Dustan, Stuart Kirk, Amanda Bradley-Stewart, Sophie Jose, Alicia Thornton, Susie Huntington, Adam Glabay, Shaadi Shidfar, Janet Lynch, James Hand, Carl de Souza, Nicky Perry, Stuart Tilbury, Elaney Youssef, Brian Gazzard, Mark Nelson, Tracey Mabika, Sundhiya Mandalia, Jane Anderson, Sajid Munshi, Frank Post, Ade Adefisan, Chris Taylor, Zachary Gleisner, Fowzia Ibrahim, Lucy Campbell, Kirsty Baillie, Richard Gilson, Nataliya Brima, Jonathan Ainsworth, Achim Schwenk, Sheila Miller, Chris Wood, Margaret Johnson, Mike Youle, Fiona Lampe, Colette Smith, Rob Tsintas, Clinton Chaloner, Samantha Hutchinson, John Walsh, Nicky Mackie, Alan Winston, Jonathan Weber, Farhan Ramzan, Mark Carder, Clifford Leen, Alan Wilson, Sheila Morris, Mark Gompels, Sue Allan, Adrian Palfreeman, Adam Lewszuk, Stephen Kegg, Akin Faleye, Victoria Ogunbiyi, Sue Mitchell, Phillip Hay, Christian Kemble, Fabiola Martin, Sarah Russell-Sharpe, Janet Gravely, Sris Allan, Andrew Harte, Anjum Tariq, Hazel Spencer, Ron Jones, Jillian Pritchard, Shirley Cumming, Claire Atkinson, Dushyant Mital, Veronica Edgell, Juli Allen, Andy Ustianowski, Cynthia Murphy, Ilise Gunder, Roy Trevelion, Abdel Babiker
Publikováno v:
Journal of Virus Eradication, Vol 5, Iss 4, Pp 204-211 (2019)
Objectives: The aim of this study was to investigate associations between baseline characteristics and CD4 cell count response on first-line antiretroviral therapy and risk of virological failure (VF) with or without drug resistance. Methods: We cond
Externí odkaz:
https://doaj.org/article/b685ef625be34b15b9ad4ef446718de6
Autor:
Oliver T. Stirrup, David T. Dunn
Publikováno v:
BMC Medical Research Methodology, Vol 18, Iss 1, Pp 1-14 (2018)
Abstract Background Minimisation of the delay to diagnosis is critical to achieving optimal outcomes for HIV patients and to limiting the potential for further onward infections. However, investigation of diagnosis delay is hampered by the fact that
Externí odkaz:
https://doaj.org/article/3919656fee0c413eade5e75f69e6da92
Autor:
Oliver T. Stirrup, David T. Dunn, Anna Tostevin, Caroline A. Sabin, Anton Pozniak, David Asboe, Alison Cox, Chloe Orkin, Fabiola Martin, Patricia Cane, the UK HIV Drug Resistance Database, the UK Collaborative HIV Cohort
Publikováno v:
AIDS Research and Therapy, Vol 15, Iss 1, Pp 1-14 (2018)
Abstract Background The prevalence of HIV-1 resistance to antiretroviral therapies (ART) has declined in high-income countries over recent years, but drug resistance remains a substantial concern in many low and middle-income countries. The Q151M and
Externí odkaz:
https://doaj.org/article/d7d3d338886b401788882d4686d70760
Publikováno v:
BMC Medical Research Methodology, Vol 16, Iss 1, Pp 1-21 (2016)
Abstract Background There has been some debate in the literature as to whether baseline values of a measurement of interest at treatment initiation should be treated as an outcome variable as part of a model for longitudinal change or instead used as
Externí odkaz:
https://doaj.org/article/eff9b0cfa0ab4adf8d6c4182bb48c3ef
Autor:
Florencia A.T. Tettamanti, Cristina Venturini, Oliver T. Stirrup, José Afonso Guerra-Assuncao, Adela Alcolea-Medina, Angela H. Becket, Matthew Byott, Themoula Charalampous, Ana da Silva Filipe, Dan Frampton, Sharon Glaysher, Tabassum Khan, Raghavendran Kulasegara-Shylini, Beatrix Kele, Irene M. Monahan, Guy Mollett, Matthew D. Parker, Emanuela Pelosi, Paul Randell, Sunando Roy, Joshua F. Taylor, Sophie J. Weller, Eleri Wilson-Davies, Phillip Wade, Rachel Williams, COG-UK HOCI Variant Substudy Consortium, Andrew Copas, Teresa Cutino-Moguel, Nick Freemantle, Andrew C Hayward, Alison Holmes, Joseph Hughes Hughes, Tabitha W. Mahungu, Gaia Nebbia, Eleni Nastouli, David G. Partridge, Cassie F. Pope, James R. Price, Samuel C. Robson, Kordo Saeed, Gee Yen Shin, Thushan I. de Silva, Luke B. Snell, Emma C. Thomson, Adam A. Witney, Judith Breuer
Publikováno v:
SSRN Electronic Journal.
Background: Recently emerging SARS-CoV-2 variants have been associated with an increased rate of transmission within the community. Little is known about the impact their increased infectivity has on transmission within hospitals. Methods: We collect
Autor:
Oliver T Stirrup 1, Jonathan Sterne 2, David T Dunn 1, Katharina Grabmeier-Pfistershammer 3, Vasileios Papastamopoulos 4, Marie-Anne Vandenhende 5 6, Ferdinand Wit 7, Kholoud Porter 1, Barbara Gunsenheimer-Bartmeyer 8, Inma Jarrin 9, Federico Garcia 10, Gerd Fätkenheuer 11, Niels Obel 12, Anna Schultze 13, Andrea Antinori 14, Francesca Ceccherini-Silberstein 15, Cristina Mussini 16, Geneviève Chêne 5 17, Bastian Neesgaard 18, Castagna A, Roger Kouyos 20, Stéphane De Wit 21, Anders Sönnerborg 22, Caroline Sabin 1, Dolores Merino 23, Diana Barger 5 17, Andrew Phillips 1
Evaluate long-term rates of virological failure and treatment interruption for people living with HIV (PLWHIV) with viral suppression on first-line efavirenz+tenofovir disoproxil fumarate+emtricitabine/lamivudine (EFV+TDF+FTC/3TC), and compare these
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10495::d4daf1819eeb2af5b3fd57a45ec724b3
Autor:
Oliver T, Stirrup, David T, Dunn
Publikováno v:
BMC Medical Research Methodology
Background Minimisation of the delay to diagnosis is critical to achieving optimal outcomes for HIV patients and to limiting the potential for further onward infections. However, investigation of diagnosis delay is hampered by the fact that in most n
Publikováno v:
BMC Medical Research Methodology, Vol 16, Iss 1, Pp 1-21 (2016)
Background There has been some debate in the literature as to whether baseline values of a measurement of interest at treatment initiation should be treated as an outcome variable as part of a model for longitudinal change or instead used as a predic